← Back to Search

Meals + Social Support for Postpartum Depression and Anxiety (MWB Trial)

N/A

Waitlist Available

Research Sponsored by Texas Tech University Health Sciences Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

MWB Trial Summary

This trial will study whether two interventions, MamaMeals and MamaMatters, can help reduce postpartum depressive or anxiety symptoms among women who are eligible for federal supplemental nutrition assistance programs.

Who is the study for?

This trial is for English-speaking women aged 18 or older who are 20-40 weeks pregnant, experiencing food insecurity, or qualify for Medicaid, WIC, SNAP, TANF. It's not for those hospitalized for mental health in the past year, with an active eating disorder, history of social media banishment, postpartum psychosis, type 1 diabetes or severe dietary restrictions.Check my eligibility

What is being tested?

The study tests MamaMeals (nutritious meal delivery) and MamaMatters (social support group) against a control group to see if they reduce symptoms of postpartum depression/anxiety and improve well-being and maternal/infant health among women with financial struggles related to food during/post-pregnancy.See study design

What are the potential side effects?

Since this trial involves meals and social support rather than medication there may be minimal side effects directly from the interventions. However indirect effects could include emotional responses to social interactions.

MWB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

% of meals delivered to and consumed by subjects

perception of the nutritious home delivered meal program

Secondary outcome measures

% of Edinburgh postnatal depression scale score >15 at 12 weeks postpartum

MWB Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Dual interventionsExperimental Treatment2 Interventions

Receive both interventions: MamaMeals and MamaMatters Interventions

Group II: Meals intervention onlyActive Control2 Interventions

MamaMeals

Group III: ControlPlacebo Group1 Intervention

Wait-list control (received MamaMeals between 16-20 weeks postpartum) (after primary data collection time point)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences CenterLead Sponsor

104 Previous Clinical Trials

10,690 Total Patients Enrolled

Media Library

Postpartum Depression Research Study Groups: Meals intervention only, Control, Dual interventions

Postpartum Depression Clinical Trial 2023: MamaMatters Highlights & Side Effects. Trial Name: NCT05484999 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still available for this research project?

"Affirmative, according to information on clinicaltrials.gov this trial is currently open for enrollment. This research was launched on May 16th 2022 and the most recent amendment occurred October 10th 2022. The study requires 84 participants from a single medical site."

Answered by AI

What is the capacity for participants of this research endeavor?

"Correct. Clinicaltrials.gov data indicates that this medical study, which was initially posted on May 16th 2022 is actively seeking participants. There are 84 patients to be recruited from one trial site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Maternal Well-Being Study

2022. "The Maternal Well-Being Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05484999.